top of page

T: +44 (0) 7919 211836

Untangling, designing
and interpreting to ensure your products succeed
Headed by a consultant biostatistician with over 25 years of experience in the pharmaceutical industry, Stone Biostatistics provides innovative solutions in optimising drug development programmes specialising in oncology.
•
Andrew Stone is a former head of the Biometrics oncology TA at AstraZeneca and has significant regulatory experience, leading biostatistics teams to the submission or approval of six oncology products
Find out more
Find out more
Find out more
Find out more
bottom of page